Hye Ryun Kim
Papers
3
Total Citations
89
H-Index
3
About
Dr. Hye Ryun Kim is a pioneering surgical oncologist whose work centers on advancing minimally invasive treatments for advanced head and neck cancers, particularly oropharyngeal and laryngo-hypopharyngeal malignancies. Her major contributions lie in integrating transoral robotic surgery (TORS) with neoadjuvant chemotherapy and customized adjuvant therapy, challenging traditional paradigms for stage III-IV disease. In her landmark 2017 study on TORS-based therapy for stage III-IV oropharyngeal squamous cell carcinoma (36 citations), she demonstrated the feasibility of robotic resection in complex tumors, reducing morbidity while maintaining oncologic control. Dr. Kim further refined this approach through two innovative clinical trials: one combining neoadjuvant chemotherapy with TORS for T3-T4 oropharyngeal cancer (27 citations), and another applying the same strategy to laryngo-hypopharyngeal tumors (26 citations). These trials established a new framework for organ preservation and functional outcomes in patients traditionally requiring radical surgery or chemoradiation. Her work has been instrumental in expanding the indications for robotic surgery to advanced-stage disease, influencing clinical guidelines and inspiring further research into de-escalation strategies. With cumulative citations exceeding 89 for these pivotal studies, Dr. Kim remains a leading voice in head and neck surgical oncology, bridging technological innovation with patient-centered care.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3